Clinical Microbial Contamination of Multidose Brimonidine: A Prospective Comparison of Benzalkonium Chloride and Purite® Preservatives
Journal of Ophthalmology · 2026-01 · 2026 (1)
DOI: 10.1155/joph/2867565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ophthalmology, online erschienen am 25.05.2026. Verfasst von Serap Karaca und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To compare microbial contamination between multidose brimonidine eye drops preserved with benzalkonium chloride (BAK‐MDB) and multidose brimonidine eye drops preserved with Purite® (PUR‐MDB) using a comparative approach on the same patient under real‐life conditions. Materials and Methods In this prospective study, 40 glaucoma patients used BAK‐MDB and PUR‐MDB for three weeks each. From each bottle, the cap and first and second drops were cultured on sheep blood and chocolate agar. Paired comparisons were performed using the exact McNemar test. Associations between patient‐related factors and contamination were evaluated using Fisher’s exact test and exploratory Firth‐penalized logistic regression.
Results
The contamination rates on the caps were similar between PUR‐MDB and BAK‐MDB on sheep blood agar (12.5% vs. 12.5%) and chocolate agar (10% vs. 12.5%) (exact McNemar test, all p > 0.05). The contamination rates of the first and second drops were lower than that of the cap, and no statistically significant difference was found between the drops (exact McNemar test, all p > 0.05). In univariate analysis, no difference was observed between contamination and patient‐related factors (all p > 0.05). In exploratory multivariate analysis, a higher education level was independently associated with a significant reduction in contamination risk (OR: 0.09; 95% CI: 0.001–0.84; p = 0.031).
Conclusion
In our study, no statistically significant difference was observed between BAK‐MDB and PUR‐MDB in terms of microbial contamination in caps, first and second drops. The exploratory association between education level and contamination risk will need to be confirmed in larger, adequately powered prospective studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey.
- Department of Medical Microbiology, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey.
- Department of Medical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey, fsmhastanesi.gov.tr.
- Department of Ophthalmology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey, medeniyet.edu.tr.
ORCID-Profile: Serap Karaca, Omer Faruk Yilmaz, Abdurrahman Sarmis, Muhammed Ali Mutlu, Zahide Busra Sahin, Sabire Pelin Kaya, Halit Oguz
Zitieren
APA
Karaca, S., Yilmaz, O. F., Sarmis, A., Mutlu, M. A., Sahin, Z. B., Kaya, S. P., & Oguz, H. (2026). Clinical Microbial Contamination of Multidose Brimonidine: A Prospective Comparison of Benzalkonium Chloride and Purite® Preservatives. Journal of Ophthalmology, 2026(1). https://doi.org/10.1155/joph/2867565
Vancouver
Karaca S, Yilmaz OF, Sarmis A, Mutlu MA, Sahin ZB, Kaya SP, et al. Clinical Microbial Contamination of Multidose Brimonidine: A Prospective Comparison of Benzalkonium Chloride and Purite® Preservatives. Journal of Ophthalmology. 2026;2026(1). doi:10.1155/joph/2867565
BibTeX
@article{Karaca2026,
author = {Karaca, Serap and Yilmaz, Omer Faruk and Sarmis, Abdurrahman and Mutlu, Muhammed Ali and Sahin, Zahide Busra and Kaya, Sabire Pelin and Oguz, Halit},
title = {Clinical Microbial Contamination of Multidose Brimonidine: A Prospective Comparison of Benzalkonium Chloride and Purite® Preservatives},
journal = {Journal of Ophthalmology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/joph/2867565}
}
EUVIMED